Baxter - 37 Year Stock Price History | BAX
Historical daily stock prices for Baxter since 1981 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Baxter (BAX) as of July 20, 2018 is 75.00.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.003B | $10.561B |
| Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $118.977B | 18.41 |
| Abbott Laboratories (ABT) | United States | $111.012B | 23.28 |
| Stryker (SYK) | United States | $65.138B | 26.05 |
| Boston Scientific (BSX) | United States | $46.596B | 25.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.697B | 14.30 |
| ResMed (RMD) | United States | $15.606B | 32.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.513B | 0.00 |
| Perrigo (PRGO) | Ireland | $10.519B | 14.75 |
| Bio-Rad Laboratories (BIO) | United States | $9.103B | 73.42 |
| Hill-Rom Holdings (HRC) | United States | $6.270B | 22.52 |
| ICU Medical (ICUI) | United States | $6.108B | 56.83 |
| Canopy Growth (CGC) | Canada | $5.270B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $5.246B | 0.00 |
| Haemonetics (HAE) | United States | $5.150B | 53.04 |
| Insulet (PODD) | United States | $5.146B | 0.00 |
| Hutchison China MediTech (HCM) | China | $4.495B | 0.00 |
| Neogen (NEOG) | United States | $4.235B | 67.72 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.061B | 0.00 |
| National Vision Holdings (EYE) | United States | $3.046B | 0.00 |
| NuVasive (NUVA) | United States | $2.748B | 27.78 |
| Quidel (QDEL) | United States | $2.607B | 114.08 |
| Phibro Animal Health (PAHC) | United States | $1.915B | 28.44 |
| Abaxis,Inc (ABAX) | United States | $1.905B | 64.08 |
| NxStage Medical (NXTM) | United States | $1.838B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.450B | 22.34 |
| Eagle Pharmaceuticals (EGRX) | United States | $1.237B | 34.60 |
| Cardiovascular Systems (CSII) | United States | $1.178B | 0.00 |
| Orthofix (OFIX) | $1.126B | 34.30 | |
| Owens & Minor (OMI) | United States | $1.078B | 10.84 |
| AtriCure (ATRC) | United States | $1.041B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.034B | 62.70 |
| Cerus (CERS) | United States | $0.982B | 0.00 |
| Omeros (OMER) | United States | $0.948B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.948B | 0.00 |
| MacroGenics (MGNX) | United States | $0.940B | 0.00 |
| Surmodics (SRDX) | United States | $0.805B | 138.07 |
| LeMaitre Vascular (LMAT) | United States | $0.709B | 41.70 |
| Meridian Bioscience (VIVO) | United States | $0.671B | 23.66 |
| PetIQ (PETQ) | United States | $0.656B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.578B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.524B | 13.70 |
| Evolus (EOLS) | United States | $0.480B | 0.00 |
| Surface Oncology (SURF) | United States | $0.363B | 0.00 |
| Quanterix (QTRX) | United States | $0.358B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.356B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.355B | 23.52 |
| NanoString Technologies (NSTG) | United States | $0.314B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.311B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.242B | 0.00 |
| Chimerix (CMRX) | United States | $0.220B | 0.00 |
| Bovie Medical (BVX) | United States | $0.172B | 0.00 |
| Fonar (FONR) | United States | $0.172B | 10.42 |
| Chembio Diagnostics (CEMI) | United States | $0.160B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.133B | 0.00 |
| Female Health (VERU) | United States | $0.110B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.104B | 31.13 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.098B | 0.00 |
| United-Guardian (UG) | United States | $0.087B | 20.43 |
| Neurotrope (NTRP) | United States | $0.079B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.073B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.056B | 0.00 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.038B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.035B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.035B | 0.00 |
| Myomo (MYO) | United States | $0.031B | 0.00 |
| Senestech (SNES) | United States | $0.027B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.003B | 0.00 |
